← Leaderboards
Jae-Hyuck Shim
Weill Medical Coll Of Cornell Univ
$4,582,838
Attributed
$6,233,952
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,233,952 · 7
By mechanism
R01$4,613,347 · 3
R21$1,620,605 · 4
Top collaborators
- Ellen M Gravallese6 shared
- Tadatoshi Sato2 shared
- Ching-Hsuan Tung2 shared
Others in their field
Top investigators on “Bone Mass”
- Peter J. Snyder · University Of Pennsylvania$32,402,680
- Judith Cheryl Gasson · University Of California Los Angeles$28,245,118
- Eric S. Orwoll · Oregon Health And Science University$26,331,629
- Joann Elisabeth Manson · Brigham And Women'S Hospital$23,818,239
- Julie E Buring · Brigham And Women'S Hospital$21,370,238
- Rose A Gubitosi-Klug · Case Western Reserve University$20,426,871
Research focus
Bone MassBoneMouse ModelPathway InteractionsProteinsIn VivoMediatingOsteoclastsIn VitroOsteoblastsOsteoporosisOsteogenesisBone LossCellsMicroctBone ResorptionOsteoblast DifferentiationLong BoneMolecularBiochemicalGrantPhenotypeOverexpressionMass Spectrum Analysis
Grant awards (19)
Development of a long-lasting, bone-targeted gene therapy for osteogenesis imperfecta$667,125
R01 · FY2025 · AR · contact PI
Novel approaches to promote healing of bone loss in inflammatory arthritis$511,095
R01 · FY2025 · AR · contact PI
Precision Gene Editing on Osteogenesis Imperfecta$165,825
R21 · FY2025 · AR
Novel approaches to promote healing of bone loss in inflammatory arthritis$509,531
R01 · FY2024 · AR · contact PI
Precision Gene Editing on Osteogenesis Imperfecta$221,100
R21 · FY2024 · AR
Novel approaches to promote healing of bone loss in inflammatory arthritis$524,436
R01 · FY2023 · AR · contact PI
Novel approaches to promote healing of bone loss in inflammatory arthritis$539,701
R01 · FY2022 · AR · contact PI
A novel bone-targeting AAV-mediated gene therapy to promote bone formation in osteoporosis$218,889
R21 · FY2022 · AR · contact PI
A novel bone-targeting AAV-mediated gene therapy to promote bone formation in osteoporosis$184,250
R21 · FY2021 · AR · contact PI
Identification of novel regulators governing osteoclast-osteoblast coupling$368,500
R01 · FY2020 · AR · contact PI
Identification of novel regulators governing osteoclast-osteoblast coupling$368,500
R01 · FY2019 · AR · contact PI
Novel approach to promote bone formation in osteoporosis using bone-homing mesenchymal stem cells$222,509
R21 · FY2019 · AR
Identification of novel regulators governing osteoclast-osteoblast coupling$368,500
R01 · FY2018 · AR · contact PI
Novel approach to promote bone formation in osteoporosis using bone-homing mesenchymal stem cells$202,682
R21 · FY2018 · AR
Novel approaches to the treatment of bone loss in rheumatoid arthritis$184,250
R21 · FY2018 · AR
Identification of novel regulators governing osteoclast-osteoblast coupling$368,500
R01 · FY2017 · AR · contact PI
Novel approaches to the treatment of bone loss in rheumatoid arthritis$221,100
R21 · FY2017 · AR
Identification of novel regulators governing osteoclast-osteoblast coupling$264,600
R01 · FY2016 · AR · contact PI
Identification of novel regulators governing osteoclast-osteoblast coupling$122,859
R01 · FY2016 · AR · contact PI